Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OFL Commemorates First Official Injured Workers’ Day and Demands Recognition Be Met with Justice
-
Kaalam LLC Unveils "Zero-Touch SDLC" Practice--Turning Code-to-Cloud Delivery into a Self-Driving Experience for Modern Software Teams
-
Camfil Releases 2024 Sustainability Report Emphasizing Transparency, Circularity, and Climate Action
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO
-
Constellis announces new offerings from Constellis Advisors & Training
-
Johnny Flash Productions Acquires Buzzquake Marketing, Expanding Digital Capabilities and Client Reach
-
The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program
-
Black Book Research Reveals the Digital Playbook Behind 2025's Top Medicare Advantage and Commercial Health Plans
-
After 40 Years, Ontario Finally Recognizes Injured Workers’ Day
-
Siemon Earns Third Consecutive Great Place To Work Certification™
-
Seagull Watch Announces Premium Line Launch and Signals Shift Toward Global High-End Market
-
VolcMiner Unveils Groundbreaking D1 Pro Miner at BTC 2025, Dominating Scrypt Mining Performance
-
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
-
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
-
Celestine Achi Launches Free AI Readiness Assessment Tool and Maturity Framework to Accelerate Africa's AI Adoption in PR, Media, and Communications
-
Xinhua Silk Road: 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament concludes with record participation
-
Revolutionary Free COI Tool by TrustLayer Improves Efficiency
-
Deepcoin Launches Futuristic Website & App Redesign to Power a High-Performance Trading Experience
-
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
-
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Introducing Artisan Bakery: A New Family of Innovative Baking Brands Launches at IDDBA 2025
-
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
-
OPPO and the UEFA Champions League Final: Powering Football Innovation On and Off the Pitch
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics
-
Green Edge Computing Corp (GECCO) and Capzul Technologies Launch End-to-End Cybersecurity on Rugged Edge Computing Appliance
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
Mining Without Machines: ZA Miner Launches Seamless Cloud Solution for Daily Crypto Rewards
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bakkt Holdings
-
Yunpeng Zhao Contributes to U.S. Risk Management System Advancing Financial Stability and Regulatory Efficiency
-
DATROWAY® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer
-
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Compass Diversified
-
ZA Miner Launches An AI-Driven Mining Protocol Ensuring Users Earn the Highest Crypto Rewards
-
Announcing Balaji Karumanchi as Founder & CEO of Excelhire – The AI-Agentic Hiring Intelligence Platform
-
Introducing Tempus One in the EHR with Integrated Guidelines
-
Breaking the Paycheck-to-Paycheck Cycle: Bitcoin Solaris Presale Phase 5 Ends in Hours—Mobile Mining App Nears Launch
-
Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer
-
IMFINZI® (durvalumab) regimen reduced risk of progression, recurrence or death by 29% in early-stage gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial
-
Strengthening Vietnam-US business partnership in the agricultural sector: Towards sustainable development and trade balance
-
Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Po
-
China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading
-
Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
-
Kite Presents New Real-World Data Supporting Use of Potentially Curative Yescarta® in Outpatient Care Setting for Patients with Relapsed/Refractory Large B-Cell Lymphoma at ASCO 2025
